NCT01406262View on ClinicalTrials.gov

Albiglutide Thorough ECG Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

94

Participants

Timeline

Start Date

July 6, 2011

Primary Completion Date

December 29, 2011

Study Completion Date

December 29, 2011

Conditions

Diabetes Mellitus, Type 2

Interventions

BIOLOGICAL

Albiglutide

once weekly subcutaneous injection

DRUG

Moxifloxacin

oral tablet

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01406262 - Albiglutide Thorough ECG Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter